Obesity and Asthma: Awareness and Self- Management (R01 Clinical Trial Optional) | PA 18 379

Opportunity Information: Apply for PA 18 379

The grant opportunity titled "Obesity and Asthma: Awareness and Self-Management (R01 Clinical Trial Optional)" (Funding Opportunity Number PA-18-379) is a National Institutes of Health (NIH) discretionary grant that supports research focused on how obesity and asthma are connected and how that relationship affects asthma awareness and self-management. The central aim is to strengthen the evidence base around the overlapping medical and behavioral factors that shape outcomes for people who have asthma and also have obesity, with particular attention to what patients understand about their condition and how effectively they manage it day to day. Because the mechanism is an R01, the opportunity is geared toward substantial, hypothesis-driven research projects that can meaningfully advance scientific knowledge in this space, and the "clinical trial optional" designation means applicants may propose studies that include a clinical trial component, but a clinical trial is not required.

The FOA sits within NIH's broader health and education-related research portfolio and is associated with CFDA number 93.361. At a practical level, it invites investigators to design and test approaches that clarify the relationship between asthma and obesity and that improve self-management awareness, which can include topics like symptom monitoring, medication adherence, trigger avoidance, action plan use, engagement with clinical care, and patient education strategies. The emphasis on "awareness" suggests interest not only in physiological or epidemiological links, but also in how individuals perceive symptoms, recognize risk, understand treatment, and respond with appropriate self-care behaviors. Projects could reasonably span observational studies, intervention development, and evaluation research, as long as they directly address the asthma-obesity-self-management intersection and add to the science in a clear, measurable way.

Eligibility is broad and includes many common applicant types such as state, county, city or township governments, special district governments, independent school districts, and public housing authorities/Indian housing authorities. Academic institutions are eligible as well, including public and state-controlled institutions of higher education and private institutions of higher education. The FOA also allows applications from federally recognized Native American tribal governments and from Native American tribal organizations that are not federally recognized governments. Both nonprofit organizations (including those with 501(c)(3) status and those without 501(c)(3) status) and for-profit organizations (other than small businesses) may apply, and small businesses are also eligible. The opportunity explicitly expands eligibility to a range of mission-driven and community-rooted institutions, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), and Tribally Controlled Colleges and Universities (TCCUs). It also notes eligibility for faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and even non-U.S. entities (foreign organizations), reflecting an intent to encourage diverse research settings and populations where asthma and obesity burdens may be substantial.

In terms of administrative details provided in the source data, the opportunity was created on December 4, 2017, and lists an original closing date of January 7, 2021. The award ceiling and expected number of awards are not specified in the excerpted information, which often means applicants need to consult the full FOA and related NIH guidance to understand budget expectations, project period norms, and institute-specific funding priorities. Overall, this announcement is aimed at building more actionable knowledge about how obesity influences asthma and how self-management awareness can be improved, with the flexibility to include clinical trials when that design is appropriate for the research question.

• The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Obesity and Asthma: Awareness and Self- Management (R01 Clinical Trial Optional)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.361.
• This funding opportunity was created on 2017-12-04.
• Applicants must submit their applications by 2021-01-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for PA 18 379

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: